Form 8 (DD) - Biocompatibles International plc

Form 8 (DD) - Biocompatibles International plc

Form 8 (DD) - Biocompatibles International plc

Form 8 (DD) - Biocompatibles International plc


Released: 25/01/2011

FORM 8 (DD)

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT

(INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code") 1. KEY INFORMATION

(a) Identity of the party to the offer or person acting in Executive Directors concert making the disclosure:

of Biocompatibles International plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant Biocompatibles securities this form relates:

International plc Use a separate form for each offeror/offeree (d) Status of person making the disclosure: Person acting in concert with the e.g. offeror, offeree, person acting in concert with offeree the offeror/offeree (specify name of offeror/offeree) (e) Date dealing undertaken: 24-25 January 2011 (f) Has the party previously disclosed, or is it today No disclosing, under the Code in respect of any other party to this offer? 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

Class of relevant security: Ordinary 21 53/94p Interests Short positions Number % Number % (1) Relevant securities owned Ian Ardill 265,586 0.65 0 0 and/or controlled: Crispin Simon and 667,678 1.63 0 0 connected persons Peter Stratford 254,111 0.62 0 0 John Sylvester 223,275 0.54 0 0 (2) Derivatives (other than 0 0 0 0 options): (3) Options and agreements to 0 0 0 0 purchase/sell: TOTAL:

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in Ordinary relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: Rights to Subscribe - Options (a) Awards granted under the Performance Share Plan (b) Interests under the No of Unvested Shares (NB Biocompatibles Share The vesting of these Incentive Plan shares is not subject to any performance conditions) Ian Ardill 9,063 Crispin Simon 9,063 Peter Stratford 9,063 John Sylvester 9,065 (c) Interests under Share Ordinary Super Option Schemes Options Options

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Name of Class of relevant Purchase/ Number of Price per director security sale securities unit (b) Derivatives transactions (other than options) Class of Product Nature of dealing Number of Price relevant description reference per security e.g. opening/closing a long/short securities unit e.g. CFD position, increasing/reducing a long/short position (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying

Name of Class of Product Writing, Number of Exercise Type Expiry Option money Director relevant description purchasing, securities to price

date paid/ security e.g. call selling, which option per unit e.g. received per option varying etc. relates American, unit European etc. (ii) Exercising Name of Class of Product description Number of Exercise Director relevant securities price per security e.g. call option unit Ian Ordinary Nil cost options under the 188,000 Nil Ardill shares Performance Share Plan 324,000 Crispin Simon 188,000 Peter 188,000 Stratford John Sylvester Crispin Ordinary Ordinary Options under 31,250 £1.89 Simon shares Executive Share Option Scheme 30,000 £0.59 Peter Stratford Crispin Ordinary Super Options under 31,250 £1.89 Simon shares Executive Share Option Scheme £0.59 (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit (if security applicable) e.g. subscription, conversion

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or

understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None (c) Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions) NO Supplemental Form 8 (SBL) NO Date of disclosure: 25 January 2011 Contact name: Ian Ardill Telephone number: +44 (0) 1252 732645

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

vendor

Back to press releases